speb/financial-data huggingface dataset:
BYL.TO income_statement (quarterly, 2025-03-31) — Selling General And Administration: 6005000.00
BYL.TO balance_sheet (quarterly, 2025-03-31) — Share Issued: 151560218.00
BYL.TO cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 403000.00
BYL.TO balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: -10453000.00
BYL.TO balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: -10453000.00
BYL.TO income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: -3204.41
BYL.TO income_statement (quarterly, 2025-03-31) — Tax Provision: -42000.00
BYL.TO income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.02
BYL.TO cash_flow (quarterly, 2025-03-31) — Taxes Refund Paid: -31000.00
BYL.TO balance_sheet (quarterly, 2025-03-31) — Total Assets: 47372000.00
BYL.TO balance_sheet (quarterly, 2025-03-31) — Total Capitalization: -5590000.00
BYL.TO balance_sheet (quarterly, 2025-03-31) — Total Debt: 30258000.00
BYL.TO balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: -10453000.00
BYL.TO income_statement (quarterly, 2025-03-31) — Total Expenses: 19999000.00
BYL.TO balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 57825000.00
BYL.TO balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 12300000.00
BYL.TO balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 13757000.00
BYL.TO income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: -1133000.00
BYL.TO income_statement (quarterly, 2025-03-31) — Total Other Finance Cost: 17000.00
BYL.TO balance_sheet (quarterly, 2025-03-31) — Total Tax Payable: 236000.00
BYL.TO income_statement (quarterly, 2025-03-31) — Total Unusual Items: -159000.00
BYL.TO income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: -159000.00
BYL.TO balance_sheet (quarterly, 2025-03-31) — Working Capital: -8996000.00
BYL.TO income_statement (quarterly, 2025-06-30) — +Operating Expense: 8648000.00
BYL.TO income_statement (quarterly, 2025-06-30) — +Total Revenue: 22456000.00
BYL.TO balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 19804000.00
BYL.TO balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 12831000.00
BYL.TO income_statement (quarterly, 2025-06-30) — Basic Average Shares: 151992901.00
BYL.TO income_statement (quarterly, 2025-06-30) — Basic EPS: 0.01
BYL.TO cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 5964000.00
BYL.TO cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -26000.00
BYL.TO balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 7491000.00
BYL.TO balance_sheet (quarterly, 2025-06-30) — Capital Stock: 188190000.00
BYL.TO balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 4290000.00
BYL.TO balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 4290000.00
BYL.TO cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: -1650000.00
BYL.TO cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -26000.00
BYL.TO cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: 188000.00
BYL.TO cash_flow (quarterly, 2025-06-30) — Cash From Discontinued Operating Activities: 0.00
BYL.TO cash_flow (quarterly, 2025-06-30) — Change In Account Payable: -3308000.00
BYL.TO cash_flow (quarterly, 2025-06-30) — Change In Inventory: 1261000.00
BYL.TO cash_flow (quarterly, 2025-06-30) — Change In Other Current Assets: 728000.00
BYL.TO cash_flow (quarterly, 2025-06-30) — Change In Payable: -3308000.00
BYL.TO cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: -3308000.00
BYL.TO cash_flow (quarterly, 2025-06-30) — Change In Receivables: -1791000.00
BYL.TO cash_flow (quarterly, 2025-06-30) — Change In Working Capital: -3110000.00
BYL.TO cash_flow (quarterly, 2025-06-30) — Changes In Account Receivables: -1791000.00
BYL.TO cash_flow (quarterly, 2025-06-30) — Changes In Cash: -1488000.00
BYL.TO balance_sheet (quarterly, 2025-06-30) — Common Stock: 188190000.00
BYL.TO balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: -8632000.00
BYL.TO income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 12051000.00
BYL.TO balance_sheet (quarterly, 2025-06-30) — Current Assets: 33356000.00
BYL.TO balance_sheet (quarterly, 2025-06-30) — Current Capital Lease Obligation: 838000.00
BYL.TO balance_sheet (quarterly, 2025-06-30) — Current Debt: 16616000.00
BYL.TO balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 17454000.00
BYL.TO balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 39628000.00
BYL.TO balance_sheet (quarterly, 2025-06-30) — Current Provisions: 2187000.00
BYL.TO cash_flow (quarterly, 2025-06-30) — Deferred Income Tax: 235000.00
BYL.TO cash_flow (quarterly, 2025-06-30) — Deferred Tax: 235000.00
BYL.TO cash_flow (quarterly, 2025-06-30) — Depreciation: 581000.00
BYL.TO cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 581000.00
BYL.TO cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 581000.00
BYL.TO income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 151992901.00
BYL.TO income_statement (quarterly, 2025-06-30) — Diluted EPS: 0.01
BYL.TO income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 1000000.00
BYL.TO income_statement (quarterly, 2025-06-30) — EBIT: 1964000.00
BYL.TO income_statement (quarterly, 2025-06-30) — EBITDA: 2545000.00
BYL.TO cash_flow (quarterly, 2025-06-30) — Earnings Losses From Equity Investments: 31000.00
BYL.TO cash_flow (quarterly, 2025-06-30) — Effect Of Exchange Rate Changes: -186000.00
BYL.TO cash_flow (quarterly, 2025-06-30) — End Cash Position: 4290000.00
BYL.TO cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: -1650000.00
BYL.TO cash_flow (quarterly, 2025-06-30) — Free Cash Flow: 162000.00
BYL.TO income_statement (quarterly, 2025-06-30) — Gain On Sale Of Security: 257000.00
BYL.TO balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: 7640000.00
BYL.TO income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 3757000.00
BYL.TO balance_sheet (quarterly, 2025-06-30) — Gross PPE: 10121000.00
BYL.TO income_statement (quarterly, 2025-06-30) — Gross Profit: 10405000.00
BYL.TO balance_sheet (quarterly, 2025-06-30) — Income Tax Payable: 183000.00
BYL.TO income_statement (quarterly, 2025-06-30) — Interest Expense: 729000.00
BYL.TO income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 729000.00
BYL.TO income_statement (quarterly, 2025-06-30) — Interest Income: 0.00
BYL.TO income_statement (quarterly, 2025-06-30) — Interest Income Non Operating: 0.00
BYL.TO cash_flow (quarterly, 2025-06-30) — Interest Paid Cfo: -727000.00
BYL.TO balance_sheet (quarterly, 2025-06-30) — Inventory: 13122000.00
BYL.TO balance_sheet (quarterly, 2025-06-30) — Invested Capital: 13143000.00
BYL.TO cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -26000.00
BYL.TO balance_sheet (quarterly, 2025-06-30) — Investments And Advances: 139000.00
BYL.TO balance_sheet (quarterly, 2025-06-30) — Line Of Credit: 16616000.00
BYL.TO balance_sheet (quarterly, 2025-06-30) — Long Term Capital Lease Obligation: 6653000.00
BYL.TO balance_sheet (quarterly, 2025-06-30) — Long Term Debt: 5159000.00
BYL.TO balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 11812000.00
BYL.TO cash_flow (quarterly, 2025-06-30) — Long Term Debt Payments: -229000.00
BYL.TO balance_sheet (quarterly, 2025-06-30) — Long Term Equity Investment: 139000.00
BYL.TO balance_sheet (quarterly, 2025-06-30) — Net Debt: 17485000.00
BYL.TO cash_flow (quarterly, 2025-06-30) — Net Foreign Currency Exchange Gain Loss: -535000.00
BYL.TO income_statement (quarterly, 2025-06-30) — Net Income: 1000000.00
BYL.TO income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 1000000.00
BYL.TO income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 1000000.00
BYL.TO income_statement (quarterly, 2025-06-30) — Net Income Discontinuous Operations: 0.00
BYL.TO income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 1000000.00
BYL.TO income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 1000000.00
BYL.TO cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: 1000000.00
BYL.TO income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 1000000.00
BYL.TO income_statement (quarterly, 2025-06-30) — Net Interest Income: -779000.00
BYL.TO cash_flow (quarterly, 2025-06-30) — Net Issuance Payments Of Debt: -1650000.00
BYL.TO cash_flow (quarterly, 2025-06-30) — Net Long Term Debt Issuance: -229000.00
BYL.TO income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -779000.00
BYL.TO balance_sheet (quarterly, 2025-06-30) — Net PPE: 10121000.00
BYL.TO cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -26000.00
BYL.TO cash_flow (quarterly, 2025-06-30) — Net Short Term Debt Issuance: -1421000.00
BYL.TO balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: -8632000.00
BYL.TO balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Liabilities: 140000.00
BYL.TO balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Liabilities: 140000.00
BYL.TO income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 2288000.00
BYL.TO income_statement (quarterly, 2025-06-30) — Normalized Income: 791902.83
BYL.TO cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: 188000.00
BYL.TO cash_flow (quarterly, 2025-06-30) — Operating Gains Losses: 250000.00
BYL.TO income_statement (quarterly, 2025-06-30) — Operating Income: 1757000.00
BYL.TO income_statement (quarterly, 2025-06-30) — Operating Revenue: 22456000.00
BYL.TO balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 152528238.00
BYL.TO balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 3113000.00
BYL.TO balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: 7640000.00
BYL.TO balance_sheet (quarterly, 2025-06-30) — Other Equity Interest: 10662000.00
BYL.TO income_statement (quarterly, 2025-06-30) — Other Gand A: 3757000.00
BYL.TO income_statement (quarterly, 2025-06-30) — Other Income Expense: 257000.00
BYL.TO cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: 747000.00
BYL.TO balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 1208000.00
BYL.TO balance_sheet (quarterly, 2025-06-30) — Other Non Current Liabilities: 176000.00
BYL.TO income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: 31000.00
BYL.TO balance_sheet (quarterly, 2025-06-30) — Other Properties: 10121000.00
BYL.TO balance_sheet (quarterly, 2025-06-30) — Payables: 19987000.00
BYL.TO balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 19987000.00
BYL.TO cash_flow (quarterly, 2025-06-30) — Pension And Employee Benefit Expense: 754000.00
BYL.TO balance_sheet (quarterly, 2025-06-30) — Preferred Securities Outside Stock Equity: 1700000.00
BYL.TO income_statement (quarterly, 2025-06-30) — Pretax Income: 1235000.00
BYL.TO cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -26000.00
BYL.TO balance_sheet (quarterly, 2025-06-30) — Receivables: 12831000.00
BYL.TO income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 12051000.00
BYL.TO income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 581000.00
BYL.TO cash_flow (quarterly, 2025-06-30) — Repayment Of Debt: -1650000.00
BYL.TO income_statement (quarterly, 2025-06-30) — Research And Development: 3111000.00
BYL.TO balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -215124000.00
BYL.TO income_statement (quarterly, 2025-06-30) — Selling And Marketing Expense: 1780000.00
BYL.TO income_statement (quarterly, 2025-06-30) — Selling General And Administration: 5537000.00
BYL.TO balance_sheet (quarterly, 2025-06-30) — Share Issued: 152528238.00
BYL.TO cash_flow (quarterly, 2025-06-30) — Short Term Debt Payments: -1421000.00
BYL.TO cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 1265000.00
BYL.TO balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: -8632000.00
BYL.TO balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: -8632000.00
BYL.TO income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 48902.83
BYL.TO income_statement (quarterly, 2025-06-30) — Tax Provision: 235000.00
BYL.TO income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.19
BYL.TO cash_flow (quarterly, 2025-06-30) — Taxes Refund Paid: -53000.00
BYL.TO balance_sheet (quarterly, 2025-06-30) — Total Assets: 44824000.00
BYL.TO balance_sheet (quarterly, 2025-06-30) — Total Capitalization: -3473000.00
BYL.TO balance_sheet (quarterly, 2025-06-30) — Total Debt: 29266000.00
BYL.TO balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: -8632000.00
BYL.TO income_statement (quarterly, 2025-06-30) — Total Expenses: 20699000.00
BYL.TO balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 53456000.00
BYL.TO balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 11468000.00
BYL.TO balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 13828000.00
BYL.TO income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: 1757000.00
BYL.TO income_statement (quarterly, 2025-06-30) — Total Other Finance Cost: 50000.00
BYL.TO balance_sheet (quarterly, 2025-06-30) — Total Tax Payable: 183000.00
BYL.TO income_statement (quarterly, 2025-06-30) — Total Unusual Items: 257000.00
BYL.TO income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: 257000.00
BYL.TO balance_sheet (quarterly, 2025-06-30) — Working Capital: -6272000.00
BYL.TO income_statement (quarterly, 2025-09-30) — +Operating Expense: 7586000.00
BYL.TO income_statement (quarterly, 2025-09-30) — +Total Revenue: 16754000.00
BYL.TO balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 21255000.00
BYL.TO balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 11567000.00
BYL.TO cash_flow (quarterly, 2025-09-30) — Amortization Cash Flow: 0.00
BYL.TO cash_flow (quarterly, 2025-09-30) — Amortization Of Intangibles: 0.00
BYL.TO income_statement (quarterly, 2025-09-30) — Basic Average Shares: 152529540.00
BYL.TO income_statement (quarterly, 2025-09-30) — Basic EPS: -0.01
BYL.TO cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 4290000.00
BYL.TO cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -13000.00
BYL.TO balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 7341000.00
BYL.TO balance_sheet (quarterly, 2025-09-30) — Capital Stock: 188226000.00
BYL.TO balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 5297000.00
BYL.TO balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 5297000.00
BYL.TO cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: 1039000.00
BYL.TO cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: -13000.00
BYL.TO cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: -111000.00
BYL.TO cash_flow (quarterly, 2025-09-30) — Cash From Discontinued Operating Activities: 0.00
BYL.TO cash_flow (quarterly, 2025-09-30) — Change In Inventory: -196000.00
BYL.TO cash_flow (quarterly, 2025-09-30) — Change In Other Current Assets: -150000.00
BYL.TO cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: -1386000.00
BYL.TO cash_flow (quarterly, 2025-09-30) — Change In Receivables: 1482000.00
BYL.TO cash_flow (quarterly, 2025-09-30) — Change In Working Capital: -250000.00
BYL.TO cash_flow (quarterly, 2025-09-30) — Changes In Account Receivables: 1482000.00
BYL.TO cash_flow (quarterly, 2025-09-30) — Changes In Cash: 915000.00
BYL.TO balance_sheet (quarterly, 2025-09-30) — Common Stock: 188226000.00
BYL.TO balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: -9855000.00
BYL.TO income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 9480000.00
BYL.TO balance_sheet (quarterly, 2025-09-30) — Current Assets: 33399000.00
BYL.TO balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 912000.00
BYL.TO balance_sheet (quarterly, 2025-09-30) — Current Debt: 16113000.00
BYL.TO balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 17025000.00
BYL.TO balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 38433000.00
BYL.TO cash_flow (quarterly, 2025-09-30) — Deferred Income Tax: -112000.00
BYL.TO cash_flow (quarterly, 2025-09-30) — Deferred Tax: -112000.00
BYL.TO cash_flow (quarterly, 2025-09-30) — Depreciation: 559000.00
BYL.TO cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 559000.00
BYL.TO cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 559000.00
BYL.TO income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 152529540.00
BYL.TO income_statement (quarterly, 2025-09-30) — Diluted EPS: -0.01
BYL.TO income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: -1100000.00
BYL.TO income_statement (quarterly, 2025-09-30) — EBIT: -519000.00
BYL.TO income_statement (quarterly, 2025-09-30) — EBITDA: 40000.00
BYL.TO cash_flow (quarterly, 2025-09-30) — Earnings Losses From Equity Investments: -165000.00
BYL.TO cash_flow (quarterly, 2025-09-30) — Effect Of Exchange Rate Changes: 92000.00
BYL.TO cash_flow (quarterly, 2025-09-30) — End Cash Position: 5297000.00
BYL.TO cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: 1039000.00
BYL.TO cash_flow (quarterly, 2025-09-30) — Free Cash Flow: -124000.00
BYL.TO income_statement (quarterly, 2025-09-30) — Gain On Sale Of Security: -182000.00
BYL.TO balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: 7350000.00
BYL.TO income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 2774000.00
BYL.TO balance_sheet (quarterly, 2025-09-30) — Gross PPE: 9723000.00
BYL.TO income_statement (quarterly, 2025-09-30) — Gross Profit: 7274000.00
BYL.TO balance_sheet (quarterly, 2025-09-30) — Income Tax Payable: 142000.00
BYL.TO income_statement (quarterly, 2025-09-30) — Interest Expense: 693000.00
BYL.TO income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 693000.00
BYL.TO income_statement (quarterly, 2025-09-30) — Interest Income: 0.00
BYL.TO income_statement (quarterly, 2025-09-30) — Interest Income Non Operating: 0.00
BYL.TO cash_flow (quarterly, 2025-09-30) — Interest Paid Cfo: -369000.00
BYL.TO balance_sheet (quarterly, 2025-09-30) — Inventory: 13430000.00
BYL.TO balance_sheet (quarterly, 2025-09-30) — Invested Capital: 11378000.00
BYL.TO cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -13000.00
BYL.TO balance_sheet (quarterly, 2025-09-30) — Investments And Advances: 314000.00
BYL.TO cash_flow (quarterly, 2025-09-30) — Issuance Of Capital Stock: 2250000.00
BYL.TO balance_sheet (quarterly, 2025-09-30) — Line Of Credit: 16113000.00
BYL.TO balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 6429000.00
BYL.TO balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 5120000.00
BYL.TO balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 11549000.00
BYL.TO cash_flow (quarterly, 2025-09-30) — Long Term Debt Payments: -203000.00
BYL.TO balance_sheet (quarterly, 2025-09-30) — Long Term Equity Investment: 314000.00
BYL.TO balance_sheet (quarterly, 2025-09-30) — Net Debt: 15936000.00
BYL.TO cash_flow (quarterly, 2025-09-30) — Net Foreign Currency Exchange Gain Loss: 799000.00
BYL.TO income_statement (quarterly, 2025-09-30) — Net Income: -1100000.00
BYL.TO income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: -1100000.00
BYL.TO income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: -1100000.00
BYL.TO income_statement (quarterly, 2025-09-30) — Net Income Discontinuous Operations: 0.00
BYL.TO income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: -1100000.00
BYL.TO income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: -1100000.00
BYL.TO cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: -1100000.00
BYL.TO income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: -1100000.00
BYL.TO income_statement (quarterly, 2025-09-30) — Net Interest Income: -718000.00
BYL.TO cash_flow (quarterly, 2025-09-30) — Net Issuance Payments Of Debt: -1211000.00
BYL.TO cash_flow (quarterly, 2025-09-30) — Net Long Term Debt Issuance: -203000.00
BYL.TO income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -718000.00
BYL.TO balance_sheet (quarterly, 2025-09-30) — Net PPE: 9723000.00
BYL.TO cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: -13000.00
BYL.TO cash_flow (quarterly, 2025-09-30) — Net Preferred Stock Issuance: 2250000.00
BYL.TO cash_flow (quarterly, 2025-09-30) — Net Short Term Debt Issuance: -1008000.00
BYL.TO balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: -9855000.00
BYL.TO balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Liabilities: 0.00
BYL.TO balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Liabilities: 0.00
BYL.TO income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 222000.00
BYL.TO income_statement (quarterly, 2025-09-30) — Normalized Income: -934818.48
BYL.TO cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: -111000.00
BYL.TO cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: 634000.00
BYL.TO income_statement (quarterly, 2025-09-30) — Operating Income: -312000.00
BYL.TO income_statement (quarterly, 2025-09-30) — Operating Revenue: 16754000.00
BYL.TO balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 152648031.00
BYL.TO balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 3105000.00
BYL.TO balance_sheet (quarterly, 2025-09-30) — Other Current Liabilities: 11000.00
BYL.TO balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: 7350000.00
BYL.TO balance_sheet (quarterly, 2025-09-30) — Other Equity Interest: 10793000.00
BYL.TO income_statement (quarterly, 2025-09-30) — Other Gand A: 2774000.00
BYL.TO income_statement (quarterly, 2025-09-30) — Other Income Expense: -182000.00
BYL.TO cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: 733000.00
BYL.TO balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 807000.00
BYL.TO balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 166000.00
BYL.TO income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: -15000.00
BYL.TO balance_sheet (quarterly, 2025-09-30) — Other Properties: 9723000.00
BYL.TO balance_sheet (quarterly, 2025-09-30) — Payables: 21397000.00
BYL.TO balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 21397000.00
BYL.TO balance_sheet (quarterly, 2025-09-30) — Preferred Securities Outside Stock Equity: 3950000.00
BYL.TO cash_flow (quarterly, 2025-09-30) — Preferred Stock Issuance: 2250000.00
BYL.TO income_statement (quarterly, 2025-09-30) — Pretax Income: -1212000.00
BYL.TO cash_flow (quarterly, 2025-09-30) — Provisionand Write Offof Assets: -193000.00
BYL.TO cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: -13000.00
BYL.TO balance_sheet (quarterly, 2025-09-30) — Receivables: 11567000.00
BYL.TO income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 9480000.00
BYL.TO income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 559000.00
BYL.TO cash_flow (quarterly, 2025-09-30) — Repayment Of Debt: -1211000.00
BYL.TO income_statement (quarterly, 2025-09-30) — Research And Development: 3073000.00
BYL.TO balance_sheet (quarterly, 2025-09-30) — Retained Earnings: -216224000.00
BYL.TO income_statement (quarterly, 2025-09-30) — Selling And Marketing Expense: 1739000.00
BYL.TO income_statement (quarterly, 2025-09-30) — Selling General And Administration: 4513000.00
BYL.TO balance_sheet (quarterly, 2025-09-30) — Share Issued: 152648031.00
BYL.TO cash_flow (quarterly, 2025-09-30) — Short Term Debt Payments: -1008000.00
BYL.TO income_statement (quarterly, 2025-09-30) — Special Income Charges: 0.00
BYL.TO cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 167000.00
BYL.TO balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: -9855000.00
BYL.TO balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: -9855000.00
BYL.TO income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: -16818.48
BYL.TO income_statement (quarterly, 2025-09-30) — Tax Provision: -112000.00
BYL.TO income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.09
BYL.TO cash_flow (quarterly, 2025-09-30) — Taxes Refund Paid: -180000.00
BYL.TO balance_sheet (quarterly, 2025-09-30) — Total Assets: 44243000.00
BYL.TO balance_sheet (quarterly, 2025-09-30) — Total Capitalization: -4735000.00
BYL.TO balance_sheet (quarterly, 2025-09-30) — Total Debt: 28574000.00
BYL.TO balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: -9855000.00
BYL.TO income_statement (quarterly, 2025-09-30) — Total Expenses: 17066000.00
BYL.TO balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 54098000.00
BYL.TO balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 10844000.00
BYL.TO balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 15665000.00
BYL.TO income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: -312000.00
BYL.TO income_statement (quarterly, 2025-09-30) — Total Other Finance Cost: 25000.00
BYL.TO balance_sheet (quarterly, 2025-09-30) — Total Tax Payable: 142000.00
BYL.TO income_statement (quarterly, 2025-09-30) — Total Unusual Items: -182000.00
BYL.TO income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: -182000.00
BYL.TO balance_sheet (quarterly, 2025-09-30) — Working Capital: -5034000.00
BYL.TO income_statement (annual, 2025-12-31) — +Operating Expense: 35224000.00
BYL.TO income_statement (quarterly, 2025-12-31) — +Operating Expense: 9854000.00
BYL.TO income_statement (annual, 2025-12-31) — +Total Revenue: 76307000.00
BYL.TO income_statement (quarterly, 2025-12-31) — +Total Revenue: 18231000.00
BYL.TO balance_sheet (annual, 2025-12-31) — Accounts Payable: 10739000.00
BYL.TO balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 10739000.00
BYL.TO balance_sheet (annual, 2025-12-31) — Accounts Receivable: 11817000.00
BYL.TO balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 11817000.00
BYL.TO balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -22274000.00
BYL.TO balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -22274000.00
BYL.TO balance_sheet (annual, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -20000.00
BYL.TO balance_sheet (quarterly, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -20000.00
BYL.TO cash_flow (annual, 2025-12-31) — Amortization Cash Flow: 0.00
BYL.TO cash_flow (quarterly, 2025-12-31) — Amortization Cash Flow: 0.00
BYL.TO cash_flow (annual, 2025-12-31) — Amortization Of Intangibles: 0.00
BYL.TO cash_flow (quarterly, 2025-12-31) — Amortization Of Intangibles: 0.00
BYL.TO cash_flow (annual, 2025-12-31) — Asset Impairment Charge: 0.00
BYL.TO income_statement (annual, 2025-12-31) — Basic Average Shares: 152135304.00
BYL.TO income_statement (annual, 2025-12-31) — Basic EPS: -0.03
BYL.TO cash_flow (annual, 2025-12-31) — Beginning Cash Position: 5006000.00
BYL.TO cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 5297000.00
BYL.TO balance_sheet (annual, 2025-12-31) — Buildings And Improvements: 6622000.00
BYL.TO balance_sheet (quarterly, 2025-12-31) — Buildings And Improvements: 6622000.00
BYL.TO cash_flow (annual, 2025-12-31) — Capital Expenditure: -57000.00
BYL.TO cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -17000.00
BYL.TO balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 2894000.00
BYL.TO balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 2894000.00
BYL.TO balance_sheet (annual, 2025-12-31) — Capital Stock: 188306000.00
BYL.TO balance_sheet (quarterly, 2025-12-31) — Capital Stock: 188306000.00
BYL.TO balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 2707000.00
BYL.TO balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 2707000.00
BYL.TO balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 2707000.00
BYL.TO balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 2707000.00
BYL.TO cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: 7358000.00
BYL.TO cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: 9706000.00
BYL.TO cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -57000.00
BYL.TO cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -17000.00
BYL.TO cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: 360000.00
BYL.TO cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: -2396000.00
BYL.TO cash_flow (annual, 2025-12-31) — Cash From Discontinued Operating Activities: 0.00
BYL.TO cash_flow (quarterly, 2025-12-31) — Cash From Discontinued Operating Activities: 0.00
BYL.TO cash_flow (annual, 2025-12-31) — Change In Account Payable: -5596000.00
BYL.TO cash_flow (annual, 2025-12-31) — Change In Inventory: 2059000.00
BYL.TO cash_flow (quarterly, 2025-12-31) — Change In Inventory: 877000.00
BYL.TO cash_flow (annual, 2025-12-31) — Change In Other Current Assets: 699000.00
BYL.TO cash_flow (quarterly, 2025-12-31) — Change In Other Current Assets: 494000.00
BYL.TO cash_flow (annual, 2025-12-31) — Change In Payable: -5596000.00
BYL.TO cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: -5596000.00
BYL.TO cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: -752000.00
BYL.TO cash_flow (annual, 2025-12-31) — Change In Receivables: 2879000.00
BYL.TO cash_flow (quarterly, 2025-12-31) — Change In Receivables: -366000.00
BYL.TO cash_flow (annual, 2025-12-31) — Change In Working Capital: 41000.00
BYL.TO cash_flow (quarterly, 2025-12-31) — Change In Working Capital: 253000.00
BYL.TO cash_flow (annual, 2025-12-31) — Changes In Account Receivables: 2879000.00
BYL.TO cash_flow (quarterly, 2025-12-31) — Changes In Account Receivables: -366000.00
BYL.TO cash_flow (annual, 2025-12-31) — Changes In Cash: 7661000.00
BYL.TO cash_flow (quarterly, 2025-12-31) — Changes In Cash: 7293000.00
BYL.TO balance_sheet (annual, 2025-12-31) — Common Stock: 188306000.00
BYL.TO balance_sheet (quarterly, 2025-12-31) — Common Stock: 188306000.00
BYL.TO balance_sheet (annual, 2025-12-31) — Common Stock Equity: -11649000.00
BYL.TO balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: -11649000.00
BYL.TO cash_flow (annual, 2025-12-31) — Common Stock Issuance: 9857000.00
BYL.TO balance_sheet (annual, 2025-12-31) — Construction In Progress: 40000.00
BYL.TO balance_sheet (quarterly, 2025-12-31) — Construction In Progress: 40000.00
BYL.TO income_statement (annual, 2025-12-31) — Cost Of Revenue: 42213000.00
BYL.TO income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 9819000.00
BYL.TO balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 7913000.00
BYL.TO balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 7913000.00
BYL.TO balance_sheet (annual, 2025-12-31) — Current Assets: 39413000.00
BYL.TO balance_sheet (quarterly, 2025-12-31) — Current Assets: 39413000.00
BYL.TO balance_sheet (annual, 2025-12-31) — Current Capital Lease Obligation: 963000.00
BYL.TO balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 963000.00
BYL.TO balance_sheet (annual, 2025-12-31) — Current Debt: 19011000.00
BYL.TO balance_sheet (quarterly, 2025-12-31) — Current Debt: 19011000.00
BYL.TO balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 19974000.00
BYL.TO balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 19974000.00
BYL.TO balance_sheet (annual, 2025-12-31) — Current Deferred Liabilities: 1991000.00
BYL.TO balance_sheet (quarterly, 2025-12-31) — Current Deferred Liabilities: 1991000.00
BYL.TO balance_sheet (annual, 2025-12-31) — Current Deferred Revenue: 1991000.00
BYL.TO balance_sheet (quarterly, 2025-12-31) — Current Deferred Revenue: 1991000.00
BYL.TO balance_sheet (annual, 2025-12-31) — Current Liabilities: 50582000.00
BYL.TO balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 50582000.00
BYL.TO cash_flow (annual, 2025-12-31) — Deferred Income Tax: 719000.00
BYL.TO cash_flow (quarterly, 2025-12-31) — Deferred Income Tax: 638000.00
BYL.TO cash_flow (annual, 2025-12-31) — Deferred Tax: 719000.00
BYL.TO cash_flow (quarterly, 2025-12-31) — Deferred Tax: 638000.00
BYL.TO cash_flow (annual, 2025-12-31) — Depreciation: 2315000.00
BYL.TO cash_flow (quarterly, 2025-12-31) — Depreciation: 567000.00
BYL.TO cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 2315000.00
BYL.TO cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 567000.00
BYL.TO cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 2315000.00
BYL.TO cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 567000.00
BYL.TO income_statement (annual, 2025-12-31) — Diluted Average Shares: 152135304.00
BYL.TO income_statement (annual, 2025-12-31) — Diluted EPS: -0.03
BYL.TO income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: -4674000.00
BYL.TO income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: -2532000.00
BYL.TO income_statement (annual, 2025-12-31) — EBIT: -1074000.00
BYL.TO income_statement (quarterly, 2025-12-31) — EBIT: -1221000.00
BYL.TO income_statement (annual, 2025-12-31) — EBITDA: 1241000.00
BYL.TO income_statement (quarterly, 2025-12-31) — EBITDA: -654000.00
BYL.TO cash_flow (annual, 2025-12-31) — Earnings Losses From Equity Investments: -68000.00
BYL.TO cash_flow (quarterly, 2025-12-31) — Earnings Losses From Equity Investments: 13000.00
BYL.TO cash_flow (annual, 2025-12-31) — Effect Of Exchange Rate Changes: -103000.00
BYL.TO cash_flow (quarterly, 2025-12-31) — Effect Of Exchange Rate Changes: -26000.00
BYL.TO cash_flow (annual, 2025-12-31) — End Cash Position: 12564000.00
BYL.TO cash_flow (quarterly, 2025-12-31) — End Cash Position: 12564000.00
BYL.TO cash_flow (annual, 2025-12-31) — Financing Cash Flow: 7358000.00
BYL.TO cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: 9706000.00
BYL.TO balance_sheet (annual, 2025-12-31) — Finished Goods: 4120000.00
BYL.TO balance_sheet (quarterly, 2025-12-31) — Finished Goods: 4120000.00
BYL.TO cash_flow (annual, 2025-12-31) — Free Cash Flow: 303000.00
BYL.TO cash_flow (quarterly, 2025-12-31) — Free Cash Flow: -2413000.00
BYL.TO income_statement (annual, 2025-12-31) — Gain On Sale Of Security: 151000.00
BYL.TO income_statement (quarterly, 2025-12-31) — Gain On Sale Of Security: 235000.00
BYL.TO balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 7803000.00
BYL.TO balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 7803000.00
BYL.TO income_statement (annual, 2025-12-31) — General And Administrative Expense: 15766000.00
BYL.TO income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 5045000.00
BYL.TO balance_sheet (annual, 2025-12-31) — Gross Accounts Receivable: 11837000.00
BYL.TO balance_sheet (quarterly, 2025-12-31) — Gross Accounts Receivable: 11837000.00
BYL.TO balance_sheet (annual, 2025-12-31) — Gross PPE: 27233000.00
BYL.TO balance_sheet (quarterly, 2025-12-31) — Gross PPE: 27233000.00
BYL.TO income_statement (annual, 2025-12-31) — Gross Profit: 34094000.00
BYL.TO income_statement (quarterly, 2025-12-31) — Gross Profit: 8412000.00
BYL.TO income_statement (annual, 2025-12-31) — Impairment Of Capital Assets: 0.00
BYL.TO balance_sheet (annual, 2025-12-31) — Income Tax Payable: 169000.00
BYL.TO balance_sheet (quarterly, 2025-12-31) — Income Tax Payable: 169000.00
BYL.TO income_statement (annual, 2025-12-31) — Interest Expense: 2881000.00
BYL.TO income_statement (quarterly, 2025-12-31) — Interest Expense: 673000.00
BYL.TO income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 2881000.00
BYL.TO income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 673000.00
BYL.TO income_statement (annual, 2025-12-31) — Interest Income: 12000.00
BYL.TO income_statement (quarterly, 2025-12-31) — Interest Income: 1000.00
BYL.TO income_statement (annual, 2025-12-31) — Interest Income Non Operating: 12000.00
BYL.TO income_statement (quarterly, 2025-12-31) — Interest Income Non Operating: 1000.00
BYL.TO cash_flow (annual, 2025-12-31) — Interest Paid Cfo: -2135000.00
BYL.TO cash_flow (quarterly, 2025-12-31) — Interest Paid Cfo: -558000.00
BYL.TO balance_sheet (annual, 2025-12-31) — Inventory: 12517000.00
BYL.TO balance_sheet (quarterly, 2025-12-31) — Inventory: 12517000.00
BYL.TO balance_sheet (annual, 2025-12-31) — Invested Capital: 7780000.00
BYL.TO balance_sheet (quarterly, 2025-12-31) — Invested Capital: 7780000.00
BYL.TO cash_flow (annual, 2025-12-31) — Investing Cash Flow: -57000.00
BYL.TO cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -17000.00
BYL.TO balance_sheet (annual, 2025-12-31) — Investments And Advances: 291000.00
BYL.TO balance_sheet (quarterly, 2025-12-31) — Investments And Advances: 291000.00
BYL.TO cash_flow (annual, 2025-12-31) — Issuance Of Capital Stock: 12107000.00
BYL.TO cash_flow (quarterly, 2025-12-31) — Issuance Of Capital Stock: 9857000.00
BYL.TO balance_sheet (annual, 2025-12-31) — Land And Improvements: 6113000.00
BYL.TO balance_sheet (quarterly, 2025-12-31) — Land And Improvements: 6113000.00
BYL.TO balance_sheet (annual, 2025-12-31) — Leases: 605000.00
BYL.TO balance_sheet (quarterly, 2025-12-31) — Leases: 605000.00
BYL.TO balance_sheet (annual, 2025-12-31) — Line Of Credit: 14684000.00
BYL.TO balance_sheet (quarterly, 2025-12-31) — Line Of Credit: 14684000.00
BYL.TO balance_sheet (annual, 2025-12-31) — Long Term Capital Lease Obligation: 1931000.00
BYL.TO balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 1931000.00
BYL.TO balance_sheet (annual, 2025-12-31) — Long Term Debt: 418000.00
BYL.TO balance_sheet (quarterly, 2025-12-31) — Long Term Debt: 418000.00
BYL.TO balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 2349000.00
BYL.TO balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 2349000.00
BYL.TO cash_flow (annual, 2025-12-31) — Long Term Debt Payments: -815000.00
BYL.TO cash_flow (quarterly, 2025-12-31) — Long Term Debt Payments: -184000.00
BYL.TO balance_sheet (annual, 2025-12-31) — Long Term Equity Investment: 291000.00
BYL.TO balance_sheet (quarterly, 2025-12-31) — Long Term Equity Investment: 291000.00
BYL.TO balance_sheet (annual, 2025-12-31) — Machinery Furniture Equipment: 13468000.00
BYL.TO balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 13468000.00
BYL.TO cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: 9857000.00
BYL.TO balance_sheet (annual, 2025-12-31) — Net Debt: 16722000.00
BYL.TO balance_sheet (quarterly, 2025-12-31) — Net Debt: 16722000.00
BYL.TO cash_flow (annual, 2025-12-31) — Net Foreign Currency Exchange Gain Loss: -95000.00
BYL.TO cash_flow (quarterly, 2025-12-31) — Net Foreign Currency Exchange Gain Loss: -348000.00
BYL.TO income_statement (annual, 2025-12-31) — Net Income: -4674000.00
BYL.TO income_statement (quarterly, 2025-12-31) — Net Income: -2532000.00
BYL.TO income_statement (annual, 2025-12-31) — Net Income Common Stockholders: -4674000.00
BYL.TO income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: -2532000.00
BYL.TO income_statement (annual, 2025-12-31) — Net Income Continuous Operations: -4674000.00
BYL.TO income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: -2532000.00
BYL.TO income_statement (annual, 2025-12-31) — Net Income Discontinuous Operations: 0.00
BYL.TO income_statement (quarterly, 2025-12-31) — Net Income Discontinuous Operations: 0.00
BYL.TO income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -4674000.00
BYL.TO income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -2532000.00
BYL.TO income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -4674000.00
BYL.TO income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -2532000.00
BYL.TO cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: -4674000.00
BYL.TO cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: -2532000.00
BYL.TO income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: -4674000.00
BYL.TO income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: -2532000.00
BYL.TO income_statement (annual, 2025-12-31) — Net Interest Income: -2976000.00
BYL.TO income_statement (quarterly, 2025-12-31) — Net Interest Income: -687000.00
BYL.TO cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: -4749000.00
BYL.TO cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: -151000.00
BYL.TO cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: -815000.00
BYL.TO cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: -184000.00
BYL.TO income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: -2976000.00
BYL.TO income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -687000.00
BYL.TO balance_sheet (annual, 2025-12-31) — Net PPE: 4959000.00
BYL.TO balance_sheet (quarterly, 2025-12-31) — Net PPE: 4959000.00
BYL.TO cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -57000.00
BYL.TO cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: -17000.00
BYL.TO cash_flow (annual, 2025-12-31) — Net Preferred Stock Issuance: 2250000.00
BYL.TO cash_flow (quarterly, 2025-12-31) — Net Preferred Stock Issuance: 0.00
BYL.TO cash_flow (annual, 2025-12-31) — Net Short Term Debt Issuance: -3934000.00
BYL.TO cash_flow (quarterly, 2025-12-31) — Net Short Term Debt Issuance: 33000.00
BYL.TO balance_sheet (annual, 2025-12-31) — Net Tangible Assets: -11649000.00
BYL.TO balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: -11649000.00
BYL.TO balance_sheet (annual, 2025-12-31) — Non Current Accounts Receivable: 714000.00
BYL.TO balance_sheet (quarterly, 2025-12-31) — Non Current Accounts Receivable: 714000.00
BYL.TO balance_sheet (annual, 2025-12-31) — Non Current Deferred Liabilities: 0.00
BYL.TO balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Liabilities: 0.00
BYL.TO balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Liabilities: 0.00
BYL.TO balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Liabilities: 0.00
BYL.TO income_statement (annual, 2025-12-31) — Normalized EBITDA: 1090000.00
BYL.TO income_statement (quarterly, 2025-12-31) — Normalized EBITDA: -889000.00
BYL.TO income_statement (annual, 2025-12-31) — Normalized Income: -4802350.00
BYL.TO income_statement (quarterly, 2025-12-31) — Normalized Income: -2731750.00
BYL.TO cash_flow (annual, 2025-12-31) — Operating Cash Flow: 360000.00
BYL.TO cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: -2396000.00
BYL.TO cash_flow (annual, 2025-12-31) — Operating Gains Losses: -163000.00
BYL.TO cash_flow (quarterly, 2025-12-31) — Operating Gains Losses: -335000.00
BYL.TO income_statement (annual, 2025-12-31) — Operating Income: -1130000.00
BYL.TO income_statement (quarterly, 2025-12-31) — Operating Income: -1442000.00
BYL.TO income_statement (annual, 2025-12-31) — Operating Revenue: 76307000.00
BYL.TO income_statement (quarterly, 2025-12-31) — Operating Revenue: 18231000.00
BYL.TO balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 152795816.00
BYL.TO balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 152795816.00
BYL.TO balance_sheet (annual, 2025-12-31) — Other Current Borrowings: 4327000.00
BYL.TO balance_sheet (quarterly, 2025-12-31) — Other Current Borrowings: 4327000.00
BYL.TO balance_sheet (annual, 2025-12-31) — Other Current Liabilities: 9209000.00
BYL.TO balance_sheet (quarterly, 2025-12-31) — Other Current Liabilities: 9209000.00
BYL.TO balance_sheet (annual, 2025-12-31) — Other Equity Adjustments: 7803000.00
BYL.TO balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: 7803000.00
BYL.TO balance_sheet (annual, 2025-12-31) — Other Equity Interest: 10998000.00
BYL.TO balance_sheet (quarterly, 2025-12-31) — Other Equity Interest: 10998000.00
BYL.TO income_statement (annual, 2025-12-31) — Other Gand A: 15766000.00
BYL.TO income_statement (quarterly, 2025-12-31) — Other Gand A: 5045000.00
BYL.TO income_statement (annual, 2025-12-31) — Other Income Expense: 151000.00
BYL.TO income_statement (quarterly, 2025-12-31) — Other Income Expense: 235000.00
BYL.TO cash_flow (annual, 2025-12-31) — Other Non Cash Items: 2060000.00
BYL.TO cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: 83000.00
BYL.TO balance_sheet (annual, 2025-12-31) — Other Non Current Liabilities: 145000.00
BYL.TO balance_sheet (quarterly, 2025-12-31) — Other Non Current Liabilities: 145000.00
BYL.TO income_statement (annual, 2025-12-31) — Other Non Operating Income Expenses: 595000.00
BYL.TO income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: 283000.00
BYL.TO balance_sheet (annual, 2025-12-31) — Other Payable: 587000.00
BYL.TO balance_sheet (quarterly, 2025-12-31) — Other Payable: 587000.00
BYL.TO balance_sheet (annual, 2025-12-31) — Other Properties: 385000.00
BYL.TO balance_sheet (quarterly, 2025-12-31) — Other Properties: 385000.00
BYL.TO balance_sheet (annual, 2025-12-31) — Other Receivables: 1548000.00
BYL.TO balance_sheet (quarterly, 2025-12-31) — Other Receivables: 1548000.00
BYL.TO balance_sheet (annual, 2025-12-31) — Payables: 11495000.00
BYL.TO balance_sheet (quarterly, 2025-12-31) — Payables: 11495000.00
BYL.TO balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 19408000.00
BYL.TO balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 19408000.00
BYL.TO balance_sheet (annual, 2025-12-31) — Preferred Securities Outside Stock Equity: 3950000.00
BYL.TO balance_sheet (quarterly, 2025-12-31) — Preferred Securities Outside Stock Equity: 3950000.00
BYL.TO cash_flow (annual, 2025-12-31) — Preferred Stock Issuance: 2250000.00
BYL.TO cash_flow (quarterly, 2025-12-31) — Preferred Stock Issuance: 0.00
BYL.TO balance_sheet (annual, 2025-12-31) — Prepaid Assets: 967000.00
BYL.TO balance_sheet (quarterly, 2025-12-31) — Prepaid Assets: 967000.00
BYL.TO income_statement (annual, 2025-12-31) — Pretax Income: -3955000.00
BYL.TO income_statement (quarterly, 2025-12-31) — Pretax Income: -1894000.00
BYL.TO balance_sheet (annual, 2025-12-31) — Properties: 0.00
BYL.TO balance_sheet (quarterly, 2025-12-31) — Properties: 0.00
BYL.TO cash_flow (annual, 2025-12-31) — Provisionand Write Offof Assets: 1153000.00
BYL.TO cash_flow (quarterly, 2025-12-31) — Provisionand Write Offof Assets: 15000.00
BYL.TO cash_flow (annual, 2025-12-31) — Purchase Of PPE: -57000.00
BYL.TO cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: -17000.00
BYL.TO balance_sheet (annual, 2025-12-31) — Raw Materials: 6890000.00
BYL.TO balance_sheet (quarterly, 2025-12-31) — Raw Materials: 6890000.00
BYL.TO balance_sheet (annual, 2025-12-31) — Receivables: 13365000.00
BYL.TO balance_sheet (quarterly, 2025-12-31) — Receivables: 13365000.00
BYL.TO income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 42213000.00
BYL.TO income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 9819000.00
BYL.TO income_statement (annual, 2025-12-31) — Reconciled Depreciation: 2315000.00
BYL.TO income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 567000.00
BYL.TO cash_flow (annual, 2025-12-31) — Repayment Of Debt: -4749000.00
BYL.TO cash_flow (quarterly, 2025-12-31) — Repayment Of Debt: -151000.00
BYL.TO income_statement (annual, 2025-12-31) — Research And Development: 12391000.00
BYL.TO income_statement (quarterly, 2025-12-31) — Research And Development: 3076000.00
BYL.TO balance_sheet (annual, 2025-12-31) — Restricted Cash: 9857000.00
BYL.TO balance_sheet (quarterly, 2025-12-31) — Restricted Cash: 9857000.00